270 related articles for article (PubMed ID: 19367274)
1. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity.
Coleman LJ; Peter MB; Teall TJ; Brannan RA; Hanby AM; Honarpisheh H; Shaaban AM; Smith L; Speirs V; Verghese ET; McElwaine JN; Hughes TA
Br J Cancer; 2009 May; 100(9):1393-9. PubMed ID: 19367274
[TBL] [Abstract][Full Text] [Related]
2. Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer.
Millican-Slater RA; Sayers CD; Hanby AM; Hughes TA
Br J Cancer; 2016 Jul; 115(3):339-45. PubMed ID: 27280636
[TBL] [Abstract][Full Text] [Related]
3. Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer.
Satheesha S; Cookson VJ; Coleman LJ; Ingram N; Madhok B; Hanby AM; Suleman CA; Sabine VS; Macaskill EJ; Bartlett JM; Dixon JM; McElwaine JN; Hughes TA
Mol Cancer; 2011 Feb; 10():19. PubMed ID: 21320304
[TBL] [Abstract][Full Text] [Related]
4. The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Ding M; Van der Kwast TH; Vellanki RN; Foltz WD; McKee TD; Sonenberg N; Pandolfi PP; Koritzinsky M; Wouters BG
Mol Cancer Res; 2018 Apr; 16(4):682-695. PubMed ID: 29453322
[TBL] [Abstract][Full Text] [Related]
5. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
6. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
[TBL] [Abstract][Full Text] [Related]
7. Structural scaffold for eIF4E binding selectivity of 4E-BP isoforms: crystal structure of eIF4E binding region of 4E-BP2 and its comparison with that of 4E-BP1.
Fukuyo A; In Y; Ishida T; Tomoo K
J Pept Sci; 2011 Sep; 17(9):650-7. PubMed ID: 21661078
[TBL] [Abstract][Full Text] [Related]
8. Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif.
Tee AR; Proud CG
Mol Cell Biol; 2002 Mar; 22(6):1674-83. PubMed ID: 11865047
[TBL] [Abstract][Full Text] [Related]
9. eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling.
Soni A; Akcakanat A; Singh G; Luyimbazi D; Zheng Y; Kim D; Gonzalez-Angulo A; Meric-Bernstam F
Mol Cancer Ther; 2008 Jul; 7(7):1782-8. PubMed ID: 18644990
[TBL] [Abstract][Full Text] [Related]
10. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
Villalonga P; Fernández de Mattos S; Ridley AJ
J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.
Seki N; Takasu T; Sawada S; Nakata M; Nishimura R; Segawa Y; Shibakuki R; Hanafusa T; Eguchi K
Lung Cancer; 2010 Dec; 70(3):329-34. PubMed ID: 20621385
[TBL] [Abstract][Full Text] [Related]
12. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
13. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
Alain T; Morita M; Fonseca BD; Yanagiya A; Siddiqui N; Bhat M; Zammit D; Marcus V; Metrakos P; Voyer LA; Gandin V; Liu Y; Topisirovic I; Sonenberg N
Cancer Res; 2012 Dec; 72(24):6468-76. PubMed ID: 23100465
[TBL] [Abstract][Full Text] [Related]
14. Translational homeostasis via the mRNA cap-binding protein, eIF4E.
Yanagiya A; Suyama E; Adachi H; Svitkin YV; Aza-Blanc P; Imataka H; Mikami S; Martineau Y; Ronai ZA; Sonenberg N
Mol Cell; 2012 Jun; 46(6):847-58. PubMed ID: 22578813
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.
Musa J; Orth MF; Dallmayer M; Baldauf M; Pardo C; Rotblat B; Kirchner T; Leprivier G; Grünewald TG
Oncogene; 2016 Sep; 35(36):4675-88. PubMed ID: 26829052
[TBL] [Abstract][Full Text] [Related]
16. Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.
Diab-Assaf M; Abou-Khouzam R; Saadallah-Zeidan N; Habib K; Bitar N; Karam W; Liagre B; Harakeh S; Azar R
Int J Clin Exp Pathol; 2015; 8(1):404-13. PubMed ID: 25755728
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic tumours escape from translational control through 4E-BP1 loss.
Martineau Y; Azar R; Müller D; Lasfargues C; El Khawand S; Anesia R; Pelletier J; Bousquet C; Pyronnet S
Oncogene; 2014 Mar; 33(11):1367-74. PubMed ID: 23563181
[TBL] [Abstract][Full Text] [Related]
18. Nuclear-targeted 4E-BP1 is dephosphorylated, induces nuclear translocation of eIF4E, and alters mRNA translation.
Takahashi S; Shibutani S; Iwata H
Exp Cell Res; 2022 Sep; 418(1):113246. PubMed ID: 35697076
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic Initiation Factor 4E phosphorylation acts a switch for its binding to 4E-BP1 and mRNA cap assembly.
Batool A; Majeed ST; Aashaq S; Majeed R; Andrabi KI
Biochem Biophys Res Commun; 2020 Jun; 527(2):489-495. PubMed ID: 32336547
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
Aguilar-Valles A; De Gregorio D; Matta-Camacho E; Eslamizade MJ; Khlaifia A; Skaleka A; Lopez-Canul M; Torres-Berrio A; Bermudez S; Rurak GM; Simard S; Salmaso N; Gobbi G; Lacaille JC; Sonenberg N
Nature; 2021 Feb; 590(7845):315-319. PubMed ID: 33328636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
